Cargando…
Mucoactive and antioxidant medicines for COPD: consensus of a group of Chinese pulmonary physicians
Airway mucus hypersecretion is a frequent symptom associated with acute and chronic airway disease. Inhibition of mucus production or promotion of mucolysis not only relieved symptoms but also improved disease outcomes. There are numerous available mucoactive medicines for prescription, and how to s...
Autores principales: | Yan, Xixin, Song, Yuanlin, Shen, Ce, Xu, Wenbing, Chen, Liangan, Zhang, Jian, Liu, Huiguo, Huang, Mao, Lai, Guoxiang, Qian, Guishen, Wang, Jing, Ye, Xianwei, Zheng, Jinping, Bai, Chunxue |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5378456/ https://www.ncbi.nlm.nih.gov/pubmed/28405161 http://dx.doi.org/10.2147/COPD.S114423 |
Ejemplares similares
-
Use of mucoactive agents in cystic fibrosis: A consensus survey of Italian specialists
por: Volpi, Sonia, et al.
Publicado: (2022) -
Mucoactive Agents in the Therapy of Upper Respiratory Airways Infections: Fair to Describe Them Just as Mucoactive?
por: Scaglione, Francesco, et al.
Publicado: (2019) -
A reappraisal of the mucoactive activity and clinical efficacy of bromhexine
por: Zanasi, Alessandro, et al.
Publicado: (2017) -
Rational use of mucoactive medications to treat pediatric airway disease
por: Linssen, R.S.N., et al.
Publicado: (2020) -
Mucoactive agent use in adult UK Critical Care Units: a survey of health care professionals’ perception, pharmacists’ description of practice, and point prevalence of mucoactive use in invasively mechanically ventilated patients
por: Borthwick, Mark, et al.
Publicado: (2020)